Analyzing the genes and peptide growth factors expressed in lung cells in vivo consequent to asbestos exposure and in vitro. by Brody, A R et al.
Analyzing the Genes and Peptide
Growth Factors Expressed in Lung Cells
in VivoConsequent to Asbestos Exposure
and in Vitro
Arnold R. Brody, Jing-Yao Liu, David Brass, and Miriam Corti
Lung Biology Program and Department of Pathology, Tulane University
Medical Center, New Orleans, Louisana
Inhalation of fibrogenic particles causes injury to the bronchiolar-alveolar epithelium. Consequently,
there is a rapid proliferative response as the epithelium recovers and interstitial mesenchymal cells
divide and produce connective tissue. In our model of brief (5-hr) exposure to chrysotile asbestos
(-1000 fibers/cc) in rats and mice, these events result in focal scarring at the bronchiolar-alveolar
duct junctions in a histopathologic pattern identical to that seen in asbestos-exposed individuals.
After 3 consecutive days of exposure, these lesions persist for at least 6 months postexposure.
We postulate that cell proliferation and production of extracellular matrix is mediated in large part
by three peptide growth factors, transforming growth factors alpha and beta (TGF-c and -P), and
platelet-derived growth factor (PDGF) A- and B-chains. To test this hypothesis in part, we have
asked whether the genes that code for these growth factor proteins are activated at sites of
asbestos-induced lung injury. If these genes were not activated, it would be reasonable to suspect
that other potent growth factors and cytokines released during lung injury could be the primary
mediators of fibroproliferative lung disease. In the studies reported here, we show, by in situ
hybridization (ISH) and immunohistochemistry, that the four genes and their concomitant proteins
are expressed within 24 hr in the bronchiolar-alveolar epithelium and underlying mesenchymal
cells. RNase protection assay and ISH showed that the PDGF gene was upregulated during the
first 5 hr of exposure and all the gene products remained above control levels for at least 2 weeks
postexposure. TGF-a is a potent mitogen for epithelial cells, whereas the PDGF isoforms are
potent growth factors for mesenchymal cells. TGF-j retards fibroblast growth but stimulates
extracellular matrix synthesis. Further studies using gene knockouts, appropriate antibodies, or
antisense technology will be necessary to prove whether any of the growth factors are playing a
significant role in fibrogenic lung disease. In addition, we have carried out a series of studies using
type 11 alveolar epithelial cells purified from adult mouse lungs and maintained for up to 8 weeks in
serum-free culture. These cells exhibit high transepithelial resistance values and they release
TGF-,1 and -P2. This cell type also has been cultured from TGF-a knockout mice, resulting in
monolayers with increased transepithelial resistance.This combination of studies in vivo and
in vitro will allow us to pursue the mechanisms through which growth factors mediate lung
fibrosis. Environ Health Perspect 105(Suppl 5):1 165-1171 (1997)
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Introduction
We have been studying the pathogenesis of monary fibrosis (1,2). If investigators can
asbestos-induced lung disease as a paradigm establish the interacting factors that mediate
for understanding the biochemical and the fibroproliferative process, it might then
molecular mechanisms of interstitial pul- be possible to develop effective therapeutic
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strategies where none now exist. Our
approach to this long-standing problem is
3-fold: a) briefexposure (1-5 hr) ofnormal
rats and mice to high concentrations
(1000-5000 fibers/cc) ofchrysotile asbestos
fibers in order to induce a fibrogenic
response and follow the temporal and
anatomic patterns ofselected growth factor
genes and proteins; b) exposure ofgeneti-
cally defined and gene knockout mice to the
asbestos aerosol in order to focus on the
potential roles of specific growth factors;
and c) long-term culture ofalveolar epithe-
lial cells from normal and genetically
defined mice to test our working hypothesis
that epithelial-derived growth factors con-
tribute to the fibroproliferative process.
Following is a summary of some of our
ongoing work in these three approaches to
understanding the mechanisms ofinterstitial
pulmonaryfibrosis.
Results and Discussion
In VivoExposures
Inhaled asbestos fibers that pass through
the airways deposit initially at the
bronchiolar-alveolar duct (BAD) regions
(1-3). Our previous studies (4,5) and sev-
eral from other laboratories (6,7) show that
the fibers induce proliferation ofepithelial
and mesenchymal cell populations. These
proliferative events can be measured by
incorporation oftritiated thymidine (4) or
bromodeoxyuridine (6-8) into DNA, or by
immunohistochemical staining ofproliferat-
ing cell nudear antigen (PCNA) (9). All the
techniques show the same results, i.e., low
background proliferative rates in the lungs
(-1%), and 5- to 30-fold increases in per-
centages ofdividing cells, depending upon
the cell types, proximity to lung injury, and
time after exposure. Inasmuch as cell prolif-
eration is essential to repair asbestos-induced
injury to the epithelium and to enlarge the
interstitial mesenchymal cell population,
which produces components ofthe extracel-
lular matrix, investigators must define which
genes and their products are controlling
these events. We are attempting to establish
whether specific growth factor genes and
their proteins are expressed with temporal
and anatomic features consistent with a role
in the disease process. At the time of this
writing, we have positive evidence for the
participation of four growth factors in the
fibroproliferative process: a) platelet-derived
growth factor (PDGF) A- and B-chains,
the most potent mesenchymal cell growth
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factor yet described (10); b) transforming
growth factor alpha (TGF-ax), a powerful
mitogen for epithelial and mesenchymal
cells (11); c) TGF-,B, a potent inducer of
extracellular matrix proteins by mesenchy-
mal cells and, at the same time, a blocker
of mesenchymal and epithelial cell
proliferation; (12) and (4) tumor necrosis
factor alpha (TNF-a), a prominent mitogen
for mesenchymal cells (13).
Platelet-derived Growth Factors.
Using in situ hybridization (ISH) of the
mRNAs coding for both the PDGF A-
and B-chain proteins, we showed that the
genes are expressed primarily in epithelial
cells and macrophages in asbestos-exposed
rats. In fact, expression was very rapid,
with both Northern analysis and ISH
demonstrating a strong signal immedi-
ately after a 5-hr exposure to chrysotile
asbestos. The message for PDGF remained
elevated for several weeks postexposure,
but only in the BAD regions where fiber
deposition, macrophage accumulation,
early epithelial injury, and cell prolif-
eration are manifested. There was no
message detected at any time in unex-
posed rats or in control animals exposed
to high concentrations of nonfibrogenic
iron spheres.
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Figure 1. (A) In situ hybridization for PDGF-B-chain gene expression on asbestos-exposed rat lung 48 hr postexposure. The sense-directed nonisotopic probe [see Liu et al.
(11) fortechnical details] shows no hybridization and only the alveolar duct lesion is seen (arrowheads). (B) The antisense probe demonstrates clear hybridization with epithe-
lial cells of the terminal bronchioles and alveolar ducts (arrowheads) as well as alveolar macrophages (arrows). (C) An antibody against human PDGF-B protein clearly stains
the epithelium and interstitium of asbestos-induced fibroproliferative lesions 48 hr after a single 5-hr exposure. Bar = 20 mm.
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Immunohistochemistry (IHC) was
used to ask ifthe PDGF A- and B-chain
peptides have been released concomitant
with the pattern of gene expression. The
answer appears at this time to be unequiv-
ocally affirmative. Figure 1 shows that the
ISH and IHC of PDGF expression coin-
cide and are localized to regions of early
lung injury. At the time of this writing,
these findings have been submitted for
consideration. The preliminary data pre-
sented here support our hypothesis that
PDGF is playing a role in the fibroprolif-
erative process because of the timing and
pattern of expression and the known bio-
logical activity ofthe factor. However, it is
very clear that this sort of information is
far from proof that PDGF is actually an
essential actor in the complex pathogenic
process. The same disclaimer can be made
for any of the factors for which we have
only descriptive information, i.e., they may
be along only for the ride, as epiphenom-
ena to the real mediators that have yet to
be defined.
Transforming Growth Factor-a. This
work has been published (11) and shows a
temporal and anatomic distribution similar
to that ofPDGF except for two interesting
differences. First, TGF-a message and pro-
tein could not be measured until 24 hr after
the 5-hr asbestos exposure. Second, the
TGF-a exhibited little interstitial message.
Actually, some TGF-ax-positive interstitial
cells could be counted at 24 hr postexpo-
sure, but this was the only time point that
significant numbers ofstained cells could be
measured in this compartment. Clara cells,
type II cells, and macrophages exhibited the
most predominant IHC reaction (11)
(Figure 2).
Transforming Growth Factor-fP. We
previously published IHC studies on the
distribution ofTGF-P in the lungs of rats
exposed to chrysotile asbestos for 3 hr (14).
Lung fibroblasts possess three classes of
receptors that bind the three main TGF-P
isoforms (12,15). The new findings shown
here demonstrate the expression of mRNA
for TGF-1I in the rats exposed to asbestos
for 5 hr (Figure 3). Again, the distribution
ofgene expression follows that ofthe pro-
tein shown by IHC. The major difference
is the intensity of the message in alveolar
epithelial cells and Clara cells ofbronchi-
oles in exposed animals. Alveolar
macrophages also showed a clear message
by ISH. As with our studies on PDGF and
TGF-a, there was no detectable TGF-3
signal by IHC or ISH in sham or iron-
exposed rats.
Exposure of Defined
Mouse Strains
Strain Differences
In the studies we are beginning to execute
on genetically defined transgenic and gene
knockout mice, it has become apparent
that all strains do not respond in a similar
fashion to inhaled agents. We exposed four
different strains ofmice to the same dose of
chrysotile asbestos (as shown by lung diges-
tion and fiber counts) and measured a con-
tinuum ofseverity. The C57 strain exhibited
the most severe lesions and the 129 strain
was essentially protected from the fibro-
genic events of a brief asbestos exposure.
Figure 2. Immunohistochemistry ofTGF-adistribution shows vivid staining, mainly in epithelial cells of bronchiolar
alveolar ductjunctions. Bar = 20 mm. Abbreviations: TB, terminal bronchioles; AD, alveolar ducts.
~~~~~~~~~~~~~~~~~~~~~.........;.;...........
Figure 3. In situhybridization of the mRNA coding forTGF-41 is clearly demonstrated after asbestos exposure in
the bronchiolar-alveolar duct epithelium (arrowheads) and alveolar macrophages (arrows). Bar = 20 pm.
Abbreviations: TB, terminal bronchioles; AD, alveolarducts.
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Figure 4. (A) H & E staining shows clear lesions developing at duct bifurcations (small arrows) in a C57B11/6 -strain
animal 48 hr after a single 5-hr asbestos exposure. (B) In a 129-strain animal similarly exposed, the same
structures do notappear differentfrom those ofcontrols.
The SJL and C57 x SJL hybrid strains
responded to a degree between that ofthe
C57 and 129 strain, but clearly more like
the C57 strains. This finding has raised the
important issue ofwhat mechanism(s) pro-
tects the 129-strain mice from asbestos-
induced lung fibrosis. Could there be
different levels of growth factor gene
expression or protein production that medi-
ate the disease process? This straightforward
question currently is being tested in our
laboratory, and preliminary datafollow.
Figure 4 shows the dramatic difference
in the fibroproliferative lesions that develop
at the BAD regions ofthe C57-strain versus
129-strain mice. The lesions of the C57
strains are the same as those we have mea-
sured extensively in rats. The responses in
the 129-strain mice were significantly
reduced, so much so that an experienced
pathologist, blinded as to the identity ofthe
mice, included most ofthe 129-strain mice
in the control (unexposed) category; this
never occurred in any C57-strain mice.
Consistent with the hypothesis that a
mitogenic factor could be playing a role in
this response, we counted the numbers of
cells incorporating bromodeoxyuridine
(BrdU) during the development of the
lesions. The C57 -strains, as expected, had
the typical approximately 10-fold increases
in numbers ofBrdU-positive cells, while the
129 strain mice exhibited significantly fewer
dividing cells through 2weeks postexposure.
At the time ofthis writing, IHC staining for
TGF-,1 was more prominent in the
C57 strain than in the 129-strain mouse.
Whether this potentially important finding
is due simply to more cells being present in
the C57 strain, or is due to an actual increase
in synthesis ofTGF-P is under rigorous
study. Since the macrophages ofthe exposed
129-strain mice exhibit little evidence of
TGF-,B staining, it is our current hypothesis
that this potent factor may be playing a cen-
tral role in the developing lesions. The mol-
ecular biology studies to test this hypothesis
are underway.
Tumor Necrosis Factor-a Receptor
KnockoutMice. TNF-a is a potent cytokine
with numerous effects on the immune sys-
tem and on multiple cell types (16). The
technology to knock out specific genes of
interest has raised new possibilities for devel-
oping an understanding ofdisease processes
(17). There are apparently two separate
membrane receptors for TNF-a, with mol-
ecular weights of 55 and 75 kDa. Mice
bred on a genetic background ofC57B1/6
and 129 had the gene coding for these
receptors knocked out. The mice appear
perfectlynormal and live a normal life span.
In preliminary studies presented here, we
are asking whether the receptors are neces-
sary for the development the of early
asbestos-induced fibroproliferative lesions
described previously. The following results
are most provocative and point toward
TNF-a as a central factor in mediating the
disease process.
As of this writing, one inhalation
experiment has been carried out and two
essential sets ofdata have been collected.
Four groups ofexperimental animals were
exposed to chrysotile asbestos fibers for 5 hr.
Four animals in each group were sacrificed
immediately after exposure and at 48 hr
postexposure. The animals were injected
with (BrdU) 5 hr before sacrifice to establish
the percentages of dividing cells in the
developing lesions. The four groups ofmice
were unexposed wild-type C57BI/6 strain
and three exposed groups, C57BI/6, an F2
hybrid ofa cross between C57BI/6 and 129
mouse strains upon which the receptor
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knockout was made, and C57BI/6-129
TNF-a-receptor knockouts. In the first
analysis, histopathologic review showed that
the exposed wild-type and C57 x 129
hybrids exhibited the typical asbestos-
induced lesions, just as in the C57 x SJL
hybrids reported above. In sharp contrast,
the blinded histopathologist could not dis-
tinguish the four asbestos-exposed receptor
knockout mice from the unexposed con-
trols. Consistent with this finding, levels of
BrdU incorporation into dividing cells were
approximately 10-fold over normal in the
asbestos-exposed C57-strain mice and
hybrid mice, whereas the unexposed and
knockout animals exhibited normal low
levels ofproliferation.
Thus, it appears that TNF-a is playing
a key role in early fibroproliferative
responses to inhaled asbestos. Whether this
factor is important in subsequent events
and the mechanisms through which TNF-
a exerts its influence in the process are the
subjects of our ongoing studies. These
experiments offer exciting new possibilities
in our search for the growth factors that are
mediatingfibroproliferative lung disease.
Long-term Culture of
Alveolar Epithelial Cells
In vitro models of the lung are powerful
tools that allow investigators to specifically
isolate cause and effect relationships
between particle-induced injury, elabora-
tion of growth factors, and cellular
responses. For example, in our laboratory
we demonstrated that asbestos stimulates
the upregulation of PDGF-x receptors on
650-
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cultured primary rat lung fibroblasts (18)
and that asbestos-stimulated macrophages
assayed in vitro elaborate elevated levels of
PDGF (19). Using more complex in vitro
models, we demonstrated that intact rat
epithelial monolayers exclude growth fac-
tors, whereas injured monolayers allow
translocation of PDGF to underlying co-
cultured fibroblasts, resulting in fibroblast
proliferation (20). Numerous other labora-
tories also have utilized in vitro models to
understand how inorganic particles interact
with cells. Lesur et al. (21) demonstrated
that silica dust directlystimulates DNAsyn-
thesis in cultured fetal alveolar epithelial
cells, andWalker et al. (22) determined that
the proliferation ofasbestos-transformed
mesothelial cells is at least partially regulated
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Figure 5. TGF-f3 andTGF-032 production as measured
by ELISA by alveolar epithelial cells and alveolar
macrophages isolated from C57B1/6 mice, cultured
alone or co-cultured. Data represents means ± SE.
aSignificantly elevated over media, p<O.005.
bSignificantly elevated over AEC alone, p<O.0001.
Abbreviations: AMo, alveolar macrophages; AEC,
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through a TGF-a-mediated autocrine
feedback mechanism.
Recently, we added to the rapid
progress in this field. We developed an in
vitro model of the alveolar epithelium
using isolated mouse type II cells. Cells are
cultured on a porous membrane support in
serum-free medium for up to 8 weeks. It
has been demonstrated previously that cul-
tured type II cells organize into continuous
monolayers with tight junctions connecting
their lateral edges. The integrity of the
monolayers and the strength ofthe junc-
tions within the monolayers can be assessed
by measuring electrical resistance across the
monolayer. This is achieved bypassing low-
level currents across the monolayers, then
measuring the ability ofthe monolayer to
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Figure 6. Particles were added to 14-day mouse alveolar epithelial monolayers. Transepithelial resistances were
measured and compared to unexposed control monolayers. Only the highest concentration chrysotile asbestos sig-
nificantly reduced resistances. Latex had no effect on resistances and iron beads appear to stabilize monolayers,
preventing the normal decrease observed in controls. Data represent means±standard errors, n=3. *Multiply by
10 for iron concentration. tLatex and asbestos concentration, 1.6 pg/cm2; iron concentration, 16 pg/cm2;
"Significantly different from unexposed controls, p<O.05. bSignificant difference between iron and asbestos,
p 0.05. cSignificant difference between iron and latex, p<0.05.
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block these currents. This is an excellent
model system for investigating aspects of
the fibroproliferative response including
a) maintenance and repair of the barrier
integrity of the monolayer after lung
injury, b) production and compartmental-
ization ofgrowth factors by epithelial cells
after injury, c) compartmentalization or
translocation ofparticles across the mono-
layer over time, and d) compartmentaliza-
tion, migration and cell-cell interactions of
macrophages and fibroblasts in co-culture
with epithelial cells.
This model represents several major
advances over previous models. One major
advance is the isolation and culture of
highly purified alveolar type II cells from
mice (23). Since its original description,
substantial improvements have been made
with mouse type II cell cultures in our lab-
oratory. To this end, our second major
advance is the long-term culture ofmouse
alveolar epithelial cells (24). Other models
of the alveolar epithelium are hampered
by rapid differentiation of cultured cells
to a type I-like phenotype that leads to
rapid attrition ofthe cells. These monolay-
ers lose their functional barrier integrity
within 2 weeks of isolation, restricting
usefulness of the cultures in the investiga-
tion of chronic diseases such as particle-
induced pulmonary fibrosis. Although
cultured type II cells from mice also differ-
entiate to type I-like cells, the process is
much slower, as determined by morpho-
logic evaluation of the cells by osmium
tetroxide, tannic acid staining, and analysis
oflight and scanning electron micrographs.
Gradually the cells appear to differentiate
to flattened type I-like cells until, by
8 weeks, 100% ofthe cells appear differen-
tiated. Monolayers formed by mouse type
II cells exhibit transepithelial resistances
that are approximately 50% higher than
those previously reported for monolayers
ofrat alveolar epithelial cells (25). This is
an average maximum resistance of 4.0
KUQcm2 across our monolayers. The cul-
tures have been maintained up to 8 weeks,
with resistances greater than 2 KU.cm2
through culture week 5. Furthermore,
long-term mouse alveolar epithelial cul-
tures are maintained in serum-free media,
allowing researchers to study the specific
effects ofgrowth factors and other soluble
peptides without the complications of
high background levels from serum. For
example, a number of molecules upregu-
late TGF-0, which stimulates matrix
production by fibroblasts (12). In our lab-
oratory, Riva et al. (26) demonstrated that
TGF-P1 and -p2, quantified by ELISA of
cell-conditioned serum-free medium, are
endogenously produced in early mouse
type II cell cultures (Figure 5), and the
production ofTGF-3 by these cells is
stimulated when co-cultured with alveolar
macrophages. These data indicate that
type II cells may be an important source of
TGF-P and that macrophages, which
increase in number dramatically at the
sites of particle-induced injury (1,2,7),
may stimulate the production ofTGF-P
by type II cells.
One powerful feature of this model is
that it allows researchers to use cells isolated
from genetically defined strains and trans-
genic mice. For example, in our laboratory,
type II cells from TGF-a knockout mice
were cultured in serum-free medium and
monitored over 4 weeks. Cells from knock-
out mice attach more rapidly, are 55%
larger, and are proportionately less numer-
ous. In addition, transepithelial resistances
are consistently elevated, averaging 40%
higher than controls, suggesting a possible
role for TGF-a in the increased permeabil-
ity ofthe alveolar epithelium observed after
lunginjury.
Similar systems can be used during
in vitro investigation of particle-induced
fibroproliferative disorders. For example,
particles were added to 14-day mouse alve-
olar epithelial monolayers after peak
transepithelial resistances had formed.
Resistances were monitored over the fol-
lowing week and compared to control
monolayers (Figure 6). Although latex par-
ticles (nonmineral controls) had no effect
on resistances, iron beads (mineral con-
trols) appeared to stabilize monolayers rela-
tive to unexposed controls, and only the
highest concentration ofchrysotile asbestos
that we used significantly reduced transep-
ithelial resistances. Further experiments are
underway to establish the mechanisms
through which asbestos increases perme-
ability ofalveolar epitheliaI cells and influ-
ences expression ofpeptide growth factors
and cytokines. These new in vitro models
of the lung will allow investigators to iso-
late direct effects ofparticles on lung cells,
to establish the specific functions ofgrowth
factors and other peptides during injury
and repair, and finally, to determine the
roles ofthese factors in the progression of
chronic lung diseases.
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